• Cucurbitacin I (JSI-124): Selective STAT3 Inhibition in Tumo

  2026-07-22

  Cucurbitacin I (JSI-124) is a potent, selective inhibitor of the JAK2/STAT3 pathway, widely used in cancer research for studying tumor cell proliferation, migration, and apoptosis. Benchmark data confirm its ability to block STAT3 DNA binding at nanomolar concentrations and suppress tumor growth in vivo with minimal toxicity. APExBIO supplies rigorously tested Cucurbitacin I for advanced research workflows.

• CTP Solution: Optimizing In Vitro Transcription & mRNA Synth

  2026-07-22

  CTP Solution (100 mM) empowers high-fidelity in vitro transcription and RNA amplification, ensuring reproducibility in the synthesis of therapeutic mRNAs. This article distills advanced workflows, troubleshooting insights, and translational use-cases in mRNA-based cancer research, with a spotlight on lipid nanoparticle delivery for localized tumor suppressor therapy.

• Bismuth Subsalicylate in Gastrointestinal Disorder Research

  2026-07-21

  Bismuth Subsalicylate is a high-purity compound central to gastrointestinal disorder research. Its mechanism as a Prostaglandin G/H Synthase 1/2 inhibitor enables precise inflammation pathway modulation and symptom relief studies. This article provides evidence-backed parameters and addresses common misconceptions.

• Iron Chelation Mitigates Nanoplastic-Induced Lung Fibroblast

  2026-07-21

  The referenced study uncovers a mechanistic link between polystyrene nanoplastics (PS-NPs) exposure and pulmonary fibrosis, highlighting the role of iron ion accumulation in promoting fibroblast proliferation and activation. Targeting iron homeostasis and intercellular crosstalk emerges as a promising therapeutic avenue for mitigating nanoplastic-induced lung pathology.

• Directed Induction of Right Ventricular Cardiomyocytes from

  2026-07-20

  Saito et al. developed a refined protocol to specifically generate right ventricular-like cardiomyocytes from human pluripotent stem cells by modulating BMP signaling during mesoderm induction. This enables more precise disease modeling and pharmacological research using chamber-specific cardiac cells.

• Methotrexate as a Folate Antagonist: Applied Protocols & Pit

  2026-07-20

  Methotrexate’s dual role as a folate antagonist and immunosuppressive agent enables precision control of apoptosis and inflammation in cellular and animal models. This article delivers actionable protocol enhancements, troubleshooting insights, and comparative workflow analysis, empowering researchers to maximize reproducibility and translational value when working with APExBIO’s Methotrexate.

• Dissecting Drug Response in Cancer: Insights from In Vitro M

  2026-07-19

  The reference dissertation establishes a nuanced framework for interpreting anti-cancer drug responses in vitro by distinguishing between growth inhibition and cell death. This approach reveals that most drugs induce both effects with distinct kinetics and magnitudes, informing more precise evaluation and comparison of therapeutic candidates.

• HNRNPU K181 Lactylation Drives Serine Metabolic Rewiring in

  2026-07-18

  This study reveals that lysine 181 lactylation of HNRNPU orchestrates serine metabolic reprogramming in cervical cancer by stabilizing PHGDH mRNA and activating the serine biosynthesis pathway. The findings provide mechanistic insight into lactate-driven tumor progression and suggest new metabolic targets for intervention.

• Cyanine 3-dCTP: Fluorescent DNA Labeling Benchmark & Mechani

  2026-07-17

  Cyanine 3-dCTP (Cy3-dCTP) is a validated fluorescent nucleotide analog enabling high-efficiency, direct enzymatic labeling of DNA and cDNA. Incorporation via standard polymerases is robust, supporting advanced applications such as PCR labeling and in situ hybridization. This dossier details atomic benchmarks, mechanisms, and verified protocol parameters, with direct product evidence and peer-reviewed synthesis data.

• Sulfo-Cy5 Carboxylic Acid: Precision Fluorescence for Transl

  2026-07-17

  Explore how Sulfo-Cy5 carboxylic acid is revolutionizing protein and peptide labeling for immunology research. This article blends mechanistic insights on dye performance with strategic guidance for translational researchers—highlighting its critical role in fluorescence imaging, immune pathway mapping, and the next generation of mucosal vaccine innovation. Practical protocol guidance, competitive analysis, and a visionary outlook for translational science are provided.

• Azathramycin A: Strategic Leverage in Tuberculosis Research

  2026-07-16

  This thought-leadership article explores Azathramycin A as a macrolide antibiotic with unique mechanistic and translational advantages in tuberculosis research. By integrating evidence from comparative macrolide efficacy studies and contemporary resistance challenges, it offers actionable guidance for translational scientists advancing Mycobacterium tuberculosis infection models, protein synthesis inhibition studies, and antibiotic resistance research. Strategic recommendations, protocol parameters, and a forward-looking outlook position this resource beyond standard product pages.

• Bispecific Anti-M1R/B6R Antibodies for Broad Orthopoxvirus P

  2026-07-16

  This study delineates the epitope and functional landscape of monoclonal antibodies targeting mpox virus antigens M1R and B6R, introducing bispecific antibody formats with enhanced antiviral efficacy. The findings inform broad-spectrum immunotherapeutic strategies against orthopoxviruses, addressing urgent gaps in mpox treatment.

• Astragalus Polysaccharides Activate Keap1-Nrf2 Pathway via m

  2026-07-15

  This study reveals how Astragalus polysaccharides (APS) protect large yellow croaker kidney cells from oxidative damage by activating the Keap1-Nrf2 antioxidant pathway through miR-183-5p. These mechanistic insights clarify APS's role in reducing apoptosis and pyroptosis, suggesting potential applications in aquaculture and oxidative stress research.

• Cyanine 3 Tyramide: Fluorescent Dye for Biomedical Research

  2026-07-15

  Cyanine 3 Tyramide delivers ultrasensitive signal amplification and spatial resolution for immunohistochemistry, in situ hybridization, and flow cytometry. Its flexibility empowers researchers to map low-abundance neurobiological targets, as demonstrated in recent studies dissecting oxytocin signaling and innate defensive behavior.

• GSK621: Unveiling AMPK Agonism for Immunometabolic Innovatio

  2026-07-14

  Explore the advanced role of GSK621 as a potent AMPK agonist and its impact on immunometabolic reprogramming. This article uniquely integrates mechanistic insights and assay decision strategies, setting it apart from existing discussions.

16365 records 1/1091 page Next 12345 下5页 Last page